Enzon Pharmaceuticals Stock Price and Value Analysis

Should you buy Enzon Pharmaceuticals stock? (Other OTC:ENZN). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

ENZN Free Cash Flow Trend

Hmm, we can't give any reliable projection for Enzon Pharmaceuticals's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for ENZN
Free Cash Flow trendline for Enzon Pharmaceuticals

Inside the ENZN Numbers

ENZN Price
(Enzon Pharmaceuticals stock price per share)
[?] PE Ratio versus Sector 89% lower than other Healthcare stocks
[?] PE Ratio versus Industry 57.8% higher than other Biotechnology stocks
[?] Cash Yield 138.53%
[?] Free Cash Flow Jitter 235%

Is Enzon Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Enzon Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ENZN Stock?

Does Enzon Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.